A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer

2013 ◽  
Vol 34 (2) ◽  
pp. 185-186 ◽  
Author(s):  
Giorgio Treglia ◽  
Antonella Stefanelli ◽  
Paola Castaldi ◽  
Vittoria Rufini
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Dual Phase ◽  
Medullary Thyroid ◽  
Pet Ct ◽  
Ct Protocol

68Ga DOTANOC PET/CT Detects Medullary Thyroid Cancer Relapse at Bone Level

2012 ◽  
Vol 37 (6) ◽  
pp. 591-592 ◽  
Author(s):  
Silvia Nicolini ◽  
Ambrosini Valentina ◽  
Fantini Lorenzo ◽  
Fanti Stefano
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Medullary Thyroid ◽  
Cancer Relapse ◽  
Pet Ct ◽  
Bone Level

Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer

2020 ◽  
Vol 34 (9) ◽  
pp. 663-674
Author(s):  
Murat Tuncel ◽  
Saadettin Kılıçkap ◽  
Nilda Süslü
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Ct Imaging ◽  
Clinical Impact ◽  
Medullary Thyroid ◽  
Pet Ct

scholarly journals Recurrent Medullary Carcinoma detected by Gallium-68 Positron Emission Tomography

2013 ◽  
Vol 5 (2) ◽  
pp. 59-60
Author(s):  
Cigdem Soydal ◽  
Mine Araz ◽  
Ozlem N Kucuk ◽  
Elgin Ozkan ◽  
Taner Demirer
Keyword(s):  
Positron Emission Tomography ◽  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Medullary Carcinoma ◽  
Emission Tomography ◽  
Thyroid Cancer Patient ◽  
Medullary Thyroid ◽  
Positron Emission ◽  
Pet Ct ◽  
Gallium 68

ABSTRACT In this case, we would like to share our experience of a recurrent medullary thyroid cancer patient whose recurrence was detected by Ga-68 DOTATATE PET/CT. How to cite this article Soydal C, Ozkan E, Araz M, Kucuk ON, Demirer T. Recurrent Medullary Carcinoma detected by Gallium-68 Positron Emission Tomography. World J Endoc Surg 2013;5(2):59-60.

PET/CT in Medullary Thyroid Cancer

2016 ◽  
pp. 881-886
Author(s):  
Iain Ross McDougall ◽  
Andrei Iagaru
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Medullary Thyroid ◽  
Pet Ct

scholarly journals Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid Cancer: Superiority in Detecting Bone Metastases

2018 ◽  
Vol 103 (9) ◽  
pp. 3250-3259 ◽  
Author(s):  
Luciana Audi Castroneves ◽  
George Coura Filho ◽  
Ricardo Miguel Costa de Freitas ◽  
Raphael Salles ◽  
Raquel Ajub Moyses ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Bone Metastases ◽  
Medullary Thyroid Cancer ◽  
Imaging Studies ◽  
Medullary Thyroid ◽  
Pet Ct

Detection of Occult Medullary Thyroid Cancer Recurrence with 2-Deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CT

2006 ◽  
Vol 9 (2) ◽  
pp. 72-77 ◽  
Author(s):  
Andrei Iagaru ◽  
Rinat Masamed ◽  
Peter A. Singer ◽  
Peter S. Conti
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Cancer Recurrence ◽  
Medullary Thyroid ◽  
Pet Ct ◽  
Thyroid Cancer Recurrence

scholarly journals Correlation between Calcitonin Levels and [F18]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Evangelia Skoura ◽  
Ioannis E. Datseris ◽  
Phivi Rondogianni ◽  
Stylianos Tsagarakis ◽  
Marinella Tzanela ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Fdg Pet ◽  
Medullary Thyroid Cancer ◽  
Recurrent Disease ◽  
True Positive ◽  
Serum Calcitonin ◽  
Medullary Thyroid ◽  
Pet Ct ◽  
Hereditary Medullary Thyroid Cancer ◽  
Fdg Pet Ct

Purpose. Measurement of serum calcitonin is important in the followup of patients with medullary thyroid carcinoma (MTC) and reliably reflects the presence of the disease. This is the largest study so far in bibliography investigating the diagnostic accuracy of combined [18F]FDG-PET/CT in patients with MTC and elevated calcitonin levels. Methods. Between February 2007 and February 2011, 59 [18F]FDG-PET/CT were performed on 51 patients with MTC and elevated calcitonin levels for localization of recurrent disease. Conventional morphologic imaging methods were negative or showed equivocal findings. Results. Among the 59 [18F]FDG-PET/CT, 29 were positive (26 had true-positive and 3 false-positive findings) and 30 negative. The overall per-patient sensitivity of [18F]FDG-PET/CT was 44.1%. Using as cut-off point the calcitonin value of 1000 pg/ml, in patients with calcitonin exceeding this value, sensitivity raised to 86.7%. The overall sensitivity of [18F]FDG-PET/CT was lower (23%) in patients with MEN IIA syndrome. Conclusion. The findings of this paper show that [18F]FDG-PET/CT is valuable for the detection of recurrence in patients with highly elevated calcitonin levels, >1000 pg/mL, but in patients with lower calcitonin levels, its contribution is questionable. Also, there is evidence that the sensitivity of [18F]FDG-PET/CT is lower in patients with MTC as part of MEN IIA syndrome.

Sign in / Sign up

Export Citation Format

Share Document